Referenzstandards von Eurofins | PHAST

USP-1598267

Raltegravir Related Compound E (20 mg) (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide)
F050W0
‭1193687-87-4‬
x
x
x